baber/WOPTO huggingface dataset:
Patent JP-2826081-B2 (JP)
IPC: A61K9/127
Filed: 1995-05-02
Granted: 1998-11-18
Abstract: New lipid vesicles have an average particle size of 0.1-20 microns and comprise a shell consisting of practically all the proteins and phospholipids present in the oil bodies of oil seeds surrounding a core comprising exogenous lipids and/or exogenous lipophilic substances. Also claimed is an aq. emulsion contg. lipid vesicles as above dispersed in an aq. phase. Also claimed is a process for preparing an aq. emulsion as above. Also claimed are cosmetic, food and therapeutic compsns. contg. lipid vesicles as above.
Patent JP-H0588238-B2 (JP)
IPC: C07D493/04
Filed: 1985-06-04
Abstract: Dianhydrohexites of the formula   <IMAGE>   wherein R1 is hydrogen or benzyl, R2 is alkyl or omega-theophyllin-7-yl-alkyl, and R1 and R2 together with the nitrogen atom to which they are attached form a bicyclic group and R3 is hydrogen, acyl, pyridylcarbonyl, nitro or a hydroxylamino group, are formed by an analogous method and used as pharmaceuticals in the treatment of heart and circulatory diseases.
Patent JP-H0413366-B2 (JP)
IPC: B05D3/02
Filed: 1982-07-30
Abstract: The invention relates to a synthetic resin based on an acrylate copolymer containing epoxide groups and having a number average molecular weight of 1,000 to 30,000. The acrylate copolymer comprises (a) 20 to 90% by weight of an alkyl acrylate having 1 to 18 carbon atoms in the alkyl radical and/or a methacrylate having 1 to 20 carbon atoms in the alkyl radical, (b) 5 to 40% by weight of a hydroxyalkyl acrylate and/or methacrylate and (c) 5 to 40% by weight of glycidyl acrylate and/or methacrylate and/or one other olefinically unsaturated, polymerizable compound carrying an epoxide group, the total amount of components a, b and c being 100%. The hydroxyl groups of the acrylate copolymer have been reacted before or after the copolymerization was carried out at least partially with a partially blocked diisocyanate and/or polyisocyanate.
Patent JP-2946837-B2 (JP)
IPC: H01L21/52
Filed: 1991-05-16
Granted: 1999-09-06
Abstract: PURPOSE:To provide a manufacture capable of forming a preform with a desired thickness (that is, desired volume) and a precise shape. CONSTITUTION:A mask 12 in which an opening with desired shape and size is formed is placed on a film 11 serving as a base. In this condition, a thin film layer 13 of a preform material with a desired thickness is formed on the film 11 and then the thin film layer 13 is removed from the film 11. By this, a manufacture of forming a preform for die bonding is provided so as to form the preform with the desired shape, size and thickness.
Patent JP-H0533353-B2 (JP)
IPC: G06Q30/04
Filed: 1985-07-02
Abstract: Quantities of radioactive material are dispersed at a user location. Billing is accomplished by monitoring the decay of material and the degree of activity following each user withdrawal.
Patent JP-H0613701-B2 (JP)
IPC: C04B28/26
Filed: 1984-07-25
Abstract: A soil injection agent on an alkali metal silicate basis, containing as gelling agent trialkoxysilanes of the formula R-Si(OR')3, in which R is an aliphatic moiety of 1 to 6 carbon atoms and R' represents equal or different alkyl moieties of 1 to 4 carbon atoms, is adjusted for properties by the addition of acid alkali metal phosphates or ammonium phosphates and/or phosphoric acid. The addition improves the sealing and strengthening action of the gels and permits a reduction of the silane content, without impairing the resistance of the gels to pollutants.
Patent JP-H0522385-B2 (JP)
IPC: G01R31/28
Filed: 1983-09-16
Abstract: 1. A method of detecting faults in VLSI-circuits (IC) using an electron probe (1) which triggers secondary electrons at test points in the VLSI-circuit (IC) - with a detector which, via a secondary electron signal, determines the actual level at the test points, - with a logic simulator (CAD-system VENUS and PRIMUS C) which serve to simulate the VLSI-circuit (IC) and to determine the theoretical level which is likely to occur at the test points with predetermined test patterns, - with a test computer (4) which controls a drive unit (2) for the VLSI-circuit (IC) and co-ordinates actual value and theoretical value, characterised in that, a) test points in the VLSI-circuit (IC) are assigned co-ordinates and the test points receive a designation and that the logic-links of the test points one in relation to another are determined, b) the VLSI-circuit (IC) is tested via the external terminals and fault paths are determined on the basis of the fault picture obtained from this test, c) the electron probe (1) is positioned at a first test point of a fault path, the appropriate test pattern is applied, and with the aid of the secondary electron signal the actual value at the test point is determined, d) the actual value at the test point is compared with the theoretical value obtained for the same test pattern from the simulation of the VLSI-circuit (IC) with the assistance of the logic simulator (CAD-system VENUS and PRIMUS C), e) the next test point in the fault path is tested in a corresponding manner and that f) the testing procedure is repeated at new test points in the test path until the fault location is localised.
Patent JP-H0682697-B2 (JP)
IPC: H01L21/52
Filed: 1988-07-15
Abstract: PURPOSE:To reduce thermal resistance of a wax material layer by increasing load of the wax material during a second period by press pressure, etc., for reducing the thickness of layer of the brazing material interposed between an electronic element and a support. CONSTITUTION:In a method for placing an electronic element 6 on a brazing material (solder) 5, heating a solder 5 for fluxing, and fixing the electronic element 6 to a support 2, the period from starting fusing of the solder 5 to any time during or after activation of flux is set to the first period, while one part of all period after the first period is set to the second period. In this case, load of the solder 5 during the second period is set lager than in the first period. Thus, the layer thickness of the solder 5 in the second period can be made smaller than that of the first period. It reduces thermal resistance of the solder 5 interposed between the electronic element 6 and the support 2.
Patent JP-3315367-B2 (JP)
IPC: C12M1/40
Filed: 1998-07-08
Granted: 2002-08-19
Abstract: PCT No. PCT/GB92/01215 Sec. 371 Date Mar. 7, 1994 Sec. 102(e) Date Mar. 7, 1994 PCT Filed Jul. 6, 1992 PCT Pub. No. WO93/01221 PCT Pub. Date Jan. 21, 1993Polymers of one or more radical polymerizable monomers which polymer has pendant groups bearing a center of permanent positive charge and other pendant groups capable of stably binding the polymer to a surface are useful in the treatment of surfaces to render them biocompatible. The polymers may contain pendant groups which bind the polymer to a surface by physisorption, covalent bonding or ionic interactions. Additionally reactive groups in the polymer may serve as points for attachment of ligands to the polymer when coated on a surface.
Patent JP-H0458824-B2 (JP)
IPC: C08J9/00
Filed: 1986-09-05
Abstract: Microporous polymeric films having good water vapor transmission rates and hydrostatic resistance to the penetration of liquid water are obtained by stretching a composition consisting of a matrix of a thermoplastic orientable polymer having a hydrophobic surface, a glass transition temperature of less than 25 DEG  C., a Vicat softening point of more than about 25 DEG  C., an ultimate elongation between those two temperatures of at least 100%, and a flexural modulus of less than 200 MPa and a particulate filler having an aspect ratio of less than 3, an average diameter of 0.05-50 m, a negligible attraction to the matrix polymer, and a surface tension no higher than that of the matrix polymer at the latter's melting temperature. Such films are useful in applications involving separation of liquids and vapors, e.g., in making "breathing" waterproof garments or linings.
Patent JP-2958656-B2 (JP)
IPC: C09D5/08
Filed: 1990-08-08
Granted: 1999-10-06
Abstract: The present invention provides coating compositions comprising     a) an organic film-forming binder; and   b) a corrosion-inhibiting amount of a salt of     i) a ketoacid having the formula (I): <CHEM> wherein a is 1,2,3,4 or 5; the R substituents are the same or different and each is hydrogen; halogen; nitro; cyano; CF3; C1-C15 alkyl; C5-C12 cycloalkyl; C2-C15 alkenyl; C1-C12 halogenoalkyl; C1-C12 alkoxy; C1-C12 thioalkyl; C6-C12 aryl; C6-C10 aryloxy; C7-C12 alkaryl; -CO2R1 in which R1 is a) hydrogen, b) C1-C20 alkyl optionally interrupted by one or more O-, N- or S-atoms, c) C7-C12 alkaryl or d) C6-C12 aryl optionally substituted with one or more carboxy groups; -COR1 in which R1 has its previous significance; NR2R3 in which R2 and R3 are the same or different and each is hydrogen or C1-C24 alkyl optionally interrupted by one or more O, S or NH moieties; or when a is 2, 3, 4 or 5, two adjacent groups R may be the atoms required to form a fused benzene or cyclohexyl ring; and n is an integer from 1 to 10; and   ii) an amine of formula II: <CHEM> wherein X, Y and Z are the same or different, and are hydrogen; C4-C24 alkyl optionally interrupted by one or more O-atoms; phenyl; C7-C9 phenylalkyl; C7-C9 alkylphenyl; or two of X, Y and Z together with the N-atom to which they are attached form a 5-, 6- or 7-membered heterocyclic residue, which optionally contains a further oxygen, nitrogen or sulphur atom and which is optionally substituted by one or more C1-C4 alkyl, amino, hydroxy, carboxy or C1-C4 carboxy alkyl groups, and the other of X, Y and Z is hydrogen; provided that X, Y and Z are not simultaneously hydrogen.     The salts derived from ketoacids of formula I and amines of formula II are new compounds.
Patent JP-H0565437-B2 (JP)
Inventor: ROOMAN PUFUISHUTERU
IPC: E02D7/08
Filed: 1990-08-17
Abstract: The invention relates to a control system with which the rope (3), drawn off from a cable drum (4) by a ramming weight (5), can be braked essentially without shocks within a predetermined overrun travel while avoiding a slack rope formation and while maintaining the selected drop height during subsequent blows, the winch drum being driven with adjustable torque by a motor (12) via a slip clutch. The torque when lifting over the height of the overrun travel is set to a threshold value which is matched to the weight of the rope and the load suspension device in such a way that the latter, but not the ramming weight (5), is lifted. After the threshold value is reached, the tensile force of the rope activates a measuring device (15) before or during the lifting of the ramming weight, which measuring device (15) measures the sectional length up to the desired drop height. When the threshold value is reached, the clutch is switched from the lower torque of the overrun travel to the torque for lifting the ramming weight or to the rated torque. The clutch is switched to free running after a rope length corresponding to the drop height is wound onto the winch, and the winch brake is engaged as soon as a rope length corresponding to the drop height has run off the winch drum. <IMAGE>
Patent JP-3972077-B2 (JP)
IPC: C08F4/24
Filed: 1991-08-28
Granted: 2007-09-05
Abstract: Polymerisation in a gas phase polymerisation reactor comprises contacting gaseous reaction mixt., contg. alpha-olefin, with a catalyst of chromium oxide associated with a granular support and activated by heat treatment, the reactor fed with alpha-olefin and catalyst at constant rates. Pref. alpha-olefin feed rate is constant using a flow regulating system, partial pressure pref. 20% min. - 40% max mixt. pressure. The total reaction mixt. pressure is predetermined min. - max. by introducing inert gas of good heat exchange capacity, (1.5-2.5 MPa), max. variations below 0.3 MPa. A chain limiter is introduced for constant partial pressure
Patent JP-2755394-B2 (JP)
IPC: C07K16/00
Filed: 1988-09-12
Granted: 1998-05-20
Abstract: Tumor Necrosis Factor (TNF) Inhibitory Protein is isolated and substantially purified. It has the ability to inhibit: (a) the binding of TNF to its receptors, and (b) the cytotoxic effect of TNF.   TNF Inhibitory Protein, salts, functional derivatives and active fractions thereof and mixtures of any of the foregoing can be used to antagonize the deleterious effects of TNF.
Patent JP-3799765-B2 (JP)
IPC: F24F11/02
Filed: 1997-08-25
Granted: 2006-07-19
Abstract: PROBLEM TO BE SOLVED: To lengthen a period of maintenance of a valve clearance. SOLUTION: A plurality of indoor machines 101-148, a plurality of outdoor machines 1-48 corresponding to the indoor machines 101-148 and a monitoring device 202 which controls the outdoor machines 1-48 and the indoor machines 101-148 and also sets the maximum number of the outdoor machines which can be started simultaneously are provided, and the outdoor machines are started simultaneously within the limits of the maximum number.
Patent JP-H088005-B2 (JP)
IPC: F21V7/16
Filed: 1989-09-19
Abstract: PURPOSE:To regulate the direction of irradiation even during failure by providing a biasing force in advance to a base so that when activated by a spring the base lowers the direction of irradiation. CONSTITUTION:A push rod 32 mounted on the lower side of a base 3 is pressed by a compression spring 33 so that the push rod 32 projects outwardly of housing 4, the top portion 32a of the push rod 32 being connected to a running wire 5 via a lever 51. The amount of movement of the running wire 5 is converted to almost its normal direction by the lever 51 and is transmitted to the push rod 32 in such a manner that the running wire 5 is pushed against the biasing force of the compression spring 33 so that the base 3 i.e. a reflecting mirror 2 irradiates a portion at angles desired by the driver. If the running rope 5 is broken, stress of the running wire 5 exerted on the push rod 32 is released and the base 3 is activated by the compression spring 33 so that the base 3 is biased to lower the optical axis of the reflecting mirror 2. Thus the direction of irradiation is regulated downward even during breakage of the running wire 5.
Patent JP-2849128-B2 (JP)
IPC: A61K31/4015
Filed: 1989-10-05
Granted: 1999-01-20
Abstract: Compounds of formula (I) and pharmaceutically acceptable acid addition salts thereof: <CHEM> wherein R represents a hydrocarbon group, X represents oxygen or sulphur, and R and -NH2 are cis; are of use in the treatment and/or prevention of neurodegenerative disorders, and are also useful as anticonvulsant agents and muscle relaxants.
Patent JP-2898735-B2 (JP)
IPC: C08G59/06
Filed: 1990-10-25
Granted: 1999-06-02
Abstract: Thermally stable methylene-bridged polyphenols such as 2,4-bis(4-hydroxy-3,5-dimethyl)-3,5-dibromo-6-methylphenol are prepared by contacting (1) a substituted phenol having at least one halogen substituted on the aromatic ring in a position meta to the phenolic hydroxyl and at least one halomethyl group substituted on the aromatic ring in a position ortho or para to the phenolic hydroxyl with (2) an o,o-dialkylphenol having hydrogen on the aromatic ring position which is para to the phenolic hydroxyl under alkylation conditions.
Patent JP-3561016-B2 (JP)
IPC: H04N7/173
Filed: 1994-12-19
Granted: 2004-09-02
Abstract: The provisioning of a multimedia application is enhanced by using a communications protocol which defines a number of different functions and which allows a multimedia application to be segmented into a plurality of logical blocks such that a user may enter a request characterizing one such function and, in response thereto, the system performs the function with respect to a particular one of the logical blocks. The underlying multimedia system is also enhanced by arranging it so that an application provider may interact with the system via a telecommunications network for the purpose of, for example, storing the application thereon and/or "debugging" the stored application. <IMAGE>
Patent JP-3131477-B2 (JP)
IPC: A23L35/00
Filed: 1991-11-29
Granted: 2001-01-31
Abstract: The invention disclosed herein comprises fat compositions primarily for use in nutritionally complete infant formulas in which the constituent palmitic acid oils and lauric acid oils are corandomized. The invention additionally includes such corandomized fat compositions with medium-chain triglycerides added, particularly for use in nutritional products for preterm or low birthweight infants. Such corandomization of two or more oils yields a mixture of triglycerides having a substantially different chemical makeup than that of the native oils themselves or than the native oils when randomized individually. Corandomization of the palmitic acid oils and the lauric acid oils affords an economical means of providing a very highly absorbed fat composition.
Patent JP-2597863-B2 (JP)
IPC: C08F222/40
Filed: 1987-12-17
Granted: 1997-04-09
Abstract: Heat-stable polymers containing imide groups. These polymers are obtained by reaction between:  - (a) one or more N,N'-bismaleimides, - (b) one or more hindered diprimary diamines of the 4,4'-diamino- 3,3',5,5'-tetraalkyldiphenylmethane or 1,3- or 1,4-diamino- trialkylbenzene type, - (c) optionally one or more monomers other than a bisimide and containing one or more polymerisable carbon-carbon double bonds,  - (d) and optionally a compound of the imidazole type. These polymers are employed especially for the production of moulded articles, laminates and articles with a cellular structure.
Patent JP-3174371-B2 (JP)
IPC: C08G18/28
Filed: 1991-12-02
Granted: 2001-06-11
Abstract: The novel polyether-ester-modified polyurethane ionomers are distinguished by high electrolyte stability and are highly suitable, in particular when mixed with perfluoroalkyl group-containing polymers, for waterproofing and oilproofing.
Patent JP-3333195-B2 (JP)
IPC: A23D9/013
Filed: 1992-05-15
Granted: 2002-10-07
Abstract: A reduced calorie fat composition comprising: (a) from about 50% to about 100% of polyol fatty acid polyesters consisting of a combination of liquid and solid polyol fatty acid polyesters, and from 0% to about 50% triglycerides. The liquid polyol fatty acid polyester having at least 50% saturated fatty acid radicals with not more than 14 carbon atoms, provides faster moisture transport than prior polyol fatty acid polyester fat compositions. As a result, foods cooked in the present compositions have good texture, crispness, mouthfeel, color, and taste with reduced calories.
Patent JP-3240348-B2 (JP)
IPC: G11C7/12
Filed: 1996-06-04
Granted: 2001-12-17
Abstract: A synchronous dynamic random access memory (SDRAM) includes a memory array and is responsive to command signals and address bits. A command decoder/controller responds to selected command signals to initiate, at different times, a precharge command, an active command, and a transfer command. The command decoder/controller initiates the active command during the precharge command. Indicating circuitry responds to the precharge command to provide a precharge complete signal indicating the completion of a precharge command operation. A row address latch responds to the active command to receive and hold a value representing a row address of the memory array as indicated by the address bits provided at the time the active command is initiated, and responds to the precharge complete signal to release the row address.
Patent JP-H0811836-B2 (JP)
IPC: C25B9/02
Filed: 1991-01-18
Abstract: PCT No. PCT/EP91/00080 Sec. 371 Date Sep. 11, 1992 Sec. 102(e) Date Sep. 11, 1992 PCT Filed Jan. 18, 1991 PCT Pub. No. WO91/14803 PCT Pub. Date Oct. 3, 1991.An electrode arrangement for electrolytic purposes has a plurality of cathodes and one or a few anodes, so that an advantageous surface ratio between cathodes and anodes results. The cathodes, provided with openings, are embodied as plates and are arranged parallel at distances from each other, the cathodes being supported in a support device with an electrically insulating surface.
Patent JP-2854137-B2 (JP)
IPC: C07K14/78
Filed: 1991-12-30
Granted: 1999-02-03
Abstract: Mineralized collagen is prepared by forming calcium phosphate mineral under mild agitation in situ in the presence of dispersed collagen fibrils. A stable composition is obtained with desirable physical characteristics mimicking the characteristics of bone.
Patent JP-2622309-B2 (JP)
IPC: B05B9/047
Filed: 1991-04-05
Granted: 1997-06-18
Abstract: The dispensing device comprises a container (12) for liquid (21) to be dispensed, an outlet nozzle (13) including means to break-up a flow of liquid under pressure into a spray, a piston (22) for forcing liquid out of the container under pressure and through the nozzle, and drive means (10) for moving the piston a predetermined distance to dispense a predetermined quantity of liquid from the container. The drive means includes a dose selector (44) for selecting the predetermined amount of liquid and a plunger (40) for moving the piston, movement of the dose selector determining subsequent movement of the plunger. The device is particularly suited to nasal administration of insulin.
Patent JP-4002613-B2 (JP)
IPC: A61F2/00
Filed: 1997-07-31
Granted: 2007-11-07
Abstract: An apparatus used in spinal surgery for creating a space of selected shape and dimensions across the disc space between adjacent vertebral bodies of the spine.
Patent JP-3623503-B2 (JP)
IPC: C11D3/48
Filed: 1993-09-30
Granted: 2005-02-23
Abstract: PCT No. PCT/EP93/02670 Sec. 371 Date May 4, 1995 Sec. 102(e) Date May 4, 1995 PCT Filed Sep. 30, 1993 PCT Pub. No. WO94/09105 PCT Pub. Date Apr. 28, 1994A clear aqueous disinfectant compositon containing the reaction product of (a) an N-substituted propylenediamine corresponding to formula I: R1,-NH-CH2-CH2-CH2-NH2 (I) in which R1 is a linear alkyl radical containing 12 to 14 carbon atoms, and (b) a compound corresponding to formula II: R2-O-CO-CH2-CH2-CH(NH2)-COOH (II) in which R2 is a hydrogen atom or an alkyl radical containing 1 to 4 carbon atoms, in a molar ration of(a) to (b) of from about 1:1 to about 1:2, respectively, and further containing (c) a solubilizer selected from the group consisting of benzyl alcohol, 2-phenoxyethanol, 1-phenoxypropanol, and mixtures thereof.
Patent JP-3375960-B2 (JP)
IPC: A61K47/44
Filed: 1992-11-25
Granted: 2003-02-10
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.